Evaluation of microRNA Gene Polymorphisms in Liver Transplant Patients with Hepatocellular Carcinoma

被引:1
|
作者
Dehbidi, Sahar [1 ]
Farokhizadeh, Zhaleh [1 ]
Karimi, Mohammad Hossein [2 ]
Afshari, Afsoon [2 ]
Behmanesh, Mehrdad [3 ]
Sanati, Mohammad Hossein [4 ]
Geramizadeh, Bita [2 ]
Yaghobi, Ramin [2 ]
机构
[1] Nour Danesh Inst Higher Educ, Fac Biol Sci, Dept Biol, Esfahan, Iran
[2] Shiraz Univ Med Sci, Shiraz Transplant Res Ctr, Shiraz, Iran
[3] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran
[4] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran
关键词
Hepatocellular Carcinoma; MicroRNA; Liver Transplantation; Rejection; Polymorphism; TURKISH POPULATION; FUNCTIONAL POLYMORPHISM; EXPRESSION PATTERNS; HUMAN CANCER; ASSOCIATION; RISK; INFECTION; SUSCEPTIBILITY; MIR-499A-GREATER-THAN-G; CONTRIBUTES;
D O I
10.5812/hepatmon.102690
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Genetic polymorphism in the miRNA sequence might alter miRNA expression and/or maturation, which is associated with the development and progression of hepatocellular carcinoma (HCC) in liver transplant patients. Objectives: Therefore, the prevalence of miRNA-146a G > C (rs2910164), miRNA-499A > G (rs3746444), miRNA-149C > T (rs2292832), and miRNA-196a-2 C > T (rs11614913) gene polymorphisms was evaluated in liver recipients with HCC with or without experiencing graft rejection. Methods: In a cross-sectional study, tissue samples were collected from 60 HCC patients who underwent liver transplant surgery at Namazi Hospital, Shiraz, Iran, in 2013 - 2015. A control group consisting of 120 individuals was randomly selected, as well. The genomic DNA was extracted from collected tissues and blood samples. The miRNA-146a (rs2910164), miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) gene polymorphisms were evaluated in patients with HCC using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results: The CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism were significantly associated with the increased risk of transplant rejection in patients with HCC (P = 0.05 and P = 0.05, respectively). The CC genotype and C allele of the miRNA-146a (rs2910164) were also significantly more frequent in male liver transplant patients who experienced acute rejection than in non-rejected ones (P = 0.05 and P = 0.03, respectively). However, no significant association was found between the genotypes and alleles of miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) polymorphisms and HCC outcomes in liver transplant recipients. Conclusions: The importance of the CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism in increasing the risk of transplant rejection was confirmed, but it needs further studies in larger populations.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [11] Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population
    Kim, Won Hee
    Min, Kyung Tae
    Jeon, Young Joo
    Kwon, Chang-Il
    Ko, Kwang Hyun
    Park, Pil Won
    Hong, Sung Pyo
    Rim, Kyu Seong
    Kwon, Sung Won
    Hwang, Seong Gyu
    Kim, Nam Keun
    GENE, 2012, 504 (01) : 92 - 97
  • [12] A New Liver Transplant Priority for Patients with Hepatocellular Carcinoma
    Ravaioli, Matteo
    Grazi, Gian Luca
    Vetrone, Gaetano
    Kimura, Takuya
    Zanello, Matteo
    Ercolani, Giorgio
    Cescon, Matteo
    Varotti, Giovanni
    Del Gaudio, Massimo
    Tuci, Francesco
    Cucchetti, Alessandro
    La Barba, Giuliano
    Vivarelli, Marco
    Lauro, Augusto
    Ramacciato, Giovanni
    Pinna, Antonio Daniele
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1742 - 1745
  • [13] The association between micro-RNA gene polymorphisms and the development of hepatocellular carcinoma in Egyptian patients
    Allam, Maha M.
    Diab, Karema A.
    Khalil, Fatma O.
    Khalaf, Fatma A.
    Abdel-Samiee, Mohamed
    Sheble, Nashwa
    Eljaky, Mohamed A.
    Zayed, Essam
    Othman, Warda
    Abd-Elkreem, Mervat
    Abdelsameea, Eman
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (01) : 62 - 70
  • [14] Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation
    Huang, Ao
    Guo, De-Zhen
    Wang, Yu-Peng
    Yang, Guo-Huan
    Sun, Qi-Man
    Zhang, Xin
    He, Yi-Feng
    Song, Kang
    Huang, Xiao-Wu
    Yang, Xin-Rong
    Fan, Jia
    Zhou, Jian
    Hu, Jie
    JOURNAL OF CANCER, 2021, 12 (23): : 7190 - 7200
  • [15] MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma
    Qiu, Guang-Ping
    Liu, Jie
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (10) : 579 - 586
  • [16] Association of four common SNPs in microRNA polymorphisms with the risk of hepatocellular carcinoma
    Li, Xinhong
    Li, Kai
    Wu, Zhongjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (08): : 9560 - 9566
  • [17] Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: A systematic review and meta-analysis
    Xu, Yumin
    Li, Liwen
    Xiang, Xiaogang
    Wang, Hui
    Cai, Wei
    Xie, Jingdong
    Han, Yan
    Bao, Shishan
    Xie, Qing
    GENE, 2013, 527 (02) : 584 - 593
  • [18] MicroRNA polymorphism: A target for diagnosis and prognosis of hepatocellular carcinoma?
    Ma, Ruixia
    Zhao, Maomao
    Zou, Xin
    Zhou, Jianye
    Bai, Zhongtian
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [19] Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy
    Yang, Zhe
    Zhou, Lin
    Wu, Li-Ming
    Xie, Hai-Yang
    Zhang, Feng
    Zheng, Shu-Sen
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (12) : 1785 - 1791
  • [20] High-resolution melting analysis reveals genetic polymorphisms in MicroRNAs confer hepatocellular carcinoma risk in Chinese patients
    Qi, Jia-Hui
    Wang, Jin
    Chen, Jinyun
    Shen, Fan
    Huang, Jing-Tao
    Sen, Subrata
    Zhou, Xin
    Liu, Song-Mei
    BMC CANCER, 2014, 14